AI High-Level Volatility Capital Rebalancing | Frequent Positive News for Innovative Drugs, Biotech ETF Worth Buying | Guest: Li Xingyu | ETF Strategy | 2026-07-02

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pinned